• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价:2009-2020 年美国妊娠期多种物质流行率估计报告。

Systematic Review: Polysubstance Prevalence Estimates Reported during Pregnancy, US, 2009-2020.

机构信息

Division of Birth Defects and Infant Disorders, National Center On Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 4770 Buford Highway, NE MS S106-3, Atlanta, GA, 30341, USA.

Eagle Global Scientific, LLC, 2835 Brandywine Rd, Suite 200, Atlanta, GA, 30341, USA.

出版信息

Matern Child Health J. 2023 Mar;27(3):426-458. doi: 10.1007/s10995-023-03592-w. Epub 2023 Feb 8.

DOI:10.1007/s10995-023-03592-w
PMID:36752906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10521102/
Abstract

INTRODUCTION

The objective of this systematic review is to describe polysubstance studies and their prevalence estimates among pregnant people in the US.

METHODS

This review was not subject to protocol preparation or registration with the International Prospective Register of Systematic Reviews (PROSPERO) because outcome data were not reported. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Checklist was followed. Four scientific literature databases were used to identify articles published from January 1, 2009 to June 3, 2020 reporting prenatal exposure to two or more substances in the US. A standardized process of title and abstract screening followed by a two-phase full-text review was used to assess study eligibility.

RESULTS

A total of 119 studies were included: 7 case-control studies, 7 clinical trials, 76 cohort studies, and 29 cross-sectional studies. Studies varied with respect to study design, time period, region, sampling and participant selection, substances assessed, and method of exposure ascertainment. Commonly reported polysubstance prevalence estimates among studies of pregnant people included combinations with alcohol, marijuana, and/or tobacco/nicotine. The range of prevalence estimates was wide (alcohol 1-99%; marijuana 3-95%; tobacco/nicotine 2-95%).

DISCUSSION

Polysubstance use during pregnancy is common, especially with alcohol, marijuana, and/or tobacco/nicotine. Future research to assess polysubstance use during pregnancy could help better describe patterns and ultimately help mitigate its effects on maternal and infant health outcomes.

摘要

简介

本系统评价的目的是描述美国孕妇的多物质使用研究及其流行率估计。

方法

由于未报告结局数据,本研究未按照国际前瞻性系统评价注册(PROSPERO)的方案进行准备或注册。本研究遵循系统评价和荟萃分析的首选报告项目(PRISMA)清单。使用四个科学文献数据库,以确定 2009 年 1 月 1 日至 2020 年 6 月 3 日在美国发表的报告产前暴露于两种或多种物质的文章。采用标题和摘要筛选的标准化程序,然后进行两阶段全文审查,以评估研究的合格性。

结果

共纳入 119 项研究:7 项病例对照研究、7 项临床试验、76 项队列研究和 29 项横断面研究。这些研究在研究设计、时间范围、地区、抽样和参与者选择、评估的物质以及暴露确定方法等方面存在差异。在对孕妇进行的多物质使用研究中,常见的报告流行率估计包括酒精、大麻和/或烟草/尼古丁的组合。流行率估计值的范围很广(酒精 1-99%;大麻 3-95%;烟草/尼古丁 2-95%)。

讨论

怀孕期间的多物质使用很常见,尤其是酒精、大麻和/或烟草/尼古丁。未来评估怀孕期间多物质使用的研究可以帮助更好地描述模式,并最终有助于减轻其对母婴健康结局的影响。

相似文献

1
Systematic Review: Polysubstance Prevalence Estimates Reported during Pregnancy, US, 2009-2020.系统评价:2009-2020 年美国妊娠期多种物质流行率估计报告。
Matern Child Health J. 2023 Mar;27(3):426-458. doi: 10.1007/s10995-023-03592-w. Epub 2023 Feb 8.
2
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
3
A systematic review of phenibut withdrawal focusing on complications, therapeutic approaches, and single substance versus polysubstance withdrawal.苯环利定戒断的系统回顾:关注并发症、治疗方法以及单一物质与多种物质戒断。
Clin Toxicol (Phila). 2023 Nov;61(11):941-951. doi: 10.1080/15563650.2023.2285702. Epub 2023 Dec 19.
4
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Analgesia use during pregnancy and risk of cryptorchidism: a systematic review and meta-analysis.孕期使用镇痛药与隐睾症风险:一项系统评价和荟萃分析。
Hum Reprod. 2017 May 1;32(5):1118-1129. doi: 10.1093/humrep/dex047.
7
Psychosocial interventions for cannabis use disorder.针对大麻使用障碍的心理社会干预措施。
Cochrane Database Syst Rev. 2016 May 5;2016(5):CD005336. doi: 10.1002/14651858.CD005336.pub4.
8
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
9
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.戒烟药物和电子烟:系统评价、网络荟萃分析和成本效益分析。
Health Technol Assess. 2021 Oct;25(59):1-224. doi: 10.3310/hta25590.
10
The Influence of Web-Based Tools on Maternal and Neonatal Outcomes in Pregnant Adolescents or Adolescent Mothers: Mixed Methods Systematic Review.基于网络的工具对青少年孕妇或未成年母亲的母婴结局的影响:混合方法系统评价。
J Med Internet Res. 2021 Aug 26;23(8):e26786. doi: 10.2196/26786.

引用本文的文献

1
Prenatal Substance Exposure.产前物质暴露
Annu Rev Dev Psychol. 2023 Dec;5(1):19-44. doi: 10.1146/annurev-devpsych-120621-043414. Epub 2023 Aug 4.
2
Perinatal insult dimensions and developmental trajectories of psychotic-like experiences.围产期损伤维度与类精神病体验的发展轨迹
Schizophrenia (Heidelb). 2025 Aug 25;11(1):115. doi: 10.1038/s41537-025-00662-6.
3
Pattern of Deep Grey Matter Undersizing Boosts MRI-Based Diagnostic Classifiers in Fetal Alcohol Spectrum Disorders.深部灰质体积减小模式增强了胎儿酒精谱系障碍中基于磁共振成像的诊断分类器。

本文引用的文献

1
US Trends in Drug Overdose Mortality Among Pregnant and Postpartum Persons, 2017-2020.2017 - 2020年美国孕妇和产后女性药物过量死亡率趋势
JAMA. 2022 Dec 6;328(21):2159-2161. doi: 10.1001/jama.2022.17045.
2
Overview of analytical methods for determining novel psychoactive substances, drugs and their metabolites in biological samples.新型精神活性物质、药物及其代谢物在生物样本中分析方法概述。
Crit Rev Toxicol. 2022 Mar;52(3):239-258. doi: 10.1080/10408444.2022.2091424.
3
What Obstetrician-Gynecologists Should Know About Substance Use Disorders in the Perinatal Period.
Hum Brain Mapp. 2025 Jun 1;46(8):e70233. doi: 10.1002/hbm.70233.
4
Pathologies in a preterm infant exposed to methamphetamine in utero: Case report and literature review.宫内暴露于甲基苯丙胺的早产儿的病理情况:病例报告及文献综述
Radiol Case Rep. 2025 Mar 15;20(6):2742-2750. doi: 10.1016/j.radcr.2025.02.032. eCollection 2025 Jun.
5
Beyond a simple cause and effect relationship: Exploring the long-term outcomes of children prenatally exposed to opioids and other substances.超越简单的因果关系:探索产前暴露于阿片类药物和其他物质的儿童的长期结局。
Semin Perinatol. 2025 Feb;49(1):152010. doi: 10.1016/j.semperi.2024.152010. Epub 2024 Dec 7.
6
Co-occurring conditions during pregnancy and hospitalizations in the first year postpartum among persons with opioid use disorder.患有阿片类药物使用障碍的人在怀孕期间和产后第一年住院期间同时存在的情况。
Prev Med. 2024 Aug;185:108057. doi: 10.1016/j.ypmed.2024.108057. Epub 2024 Jun 26.
7
Perception of pregnant individuals, health providers and decision makers on interventions to cease substance consumption during pregnancy: a qualitative study.孕妇、卫生保健提供者和决策者对孕期停止物质使用干预措施的看法:一项定性研究。
BMC Public Health. 2024 Apr 9;24(1):990. doi: 10.1186/s12889-024-18397-x.
8
Programs and practices that support pregnant people who use drugs' access to sexual and reproductive health care in Canada: a scoping review.支持加拿大吸毒孕妇获得性健康和生殖健康护理的项目和实践:范围综述。
BMC Pregnancy Childbirth. 2024 Jan 22;24(1):72. doi: 10.1186/s12884-023-06225-w.
9
Advances in the Care of Infants With Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome.产前阿片暴露和新生儿阿片戒断综合征婴儿护理的进展。
Pediatrics. 2024 Jan 1;153(2). doi: 10.1542/peds.2023-062871.
10
Investigating the associations between prenatal exposure to substances and intergenerational maltreatment and symptoms of psychopathology for adolescent girls from families with low income.探讨物质暴露与代际虐待以及来自低收入家庭的青春期女孩精神病理学症状之间的关联。
Child Abuse Negl. 2024 Jan;147:106594. doi: 10.1016/j.chiabu.2023.106594. Epub 2023 Dec 11.
围产期物质使用障碍:妇产科医生须知
Obstet Gynecol. 2022 Feb 1;139(2):317-337. doi: 10.1097/AOG.0000000000004657.
4
The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.非法芬太尼、兴奋剂的兴起和阿片类药物过量危机的第四波。
Curr Opin Psychiatry. 2021 Jul 1;34(4):344-350. doi: 10.1097/YCO.0000000000000717.
5
Delivery dose of methadone, but not buprenorphine, is associated with the risk and severity of neonatal opiate withdrawal syndrome.美沙酮的给药剂量与新生儿阿片类戒断综合征的风险和严重程度有关,但布比卡因则不然。
Am J Obstet Gynecol MFM. 2020 Feb;2(1):100075. doi: 10.1016/j.ajogmf.2019.100075. Epub 2019 Dec 10.
6
Pregnancy-Associated Deaths from Homicide, Suicide, and Drug Overdose: Review of Research and the Intersection with Intimate Partner Violence.妊娠相关的他杀、自杀和药物过量死亡:研究综述及其与亲密伴侣暴力的交叉情况
J Womens Health (Larchmt). 2021 Feb;30(2):236-244. doi: 10.1089/jwh.2020.8875. Epub 2020 Dec 8.
7
Co-occurring Substance Use Disorders Identified Among Delivery Hospitalizations in the United States.在美国的分娩住院患者中发现了共病物质使用障碍。
J Addict Med. 2021;15(6):504-507. doi: 10.1097/ADM.0000000000000792.
8
Neonatal Opioid Withdrawal Syndrome.新生儿阿片类戒断综合征。
Pediatrics. 2020 Nov;146(5). doi: 10.1542/peds.2020-029074.
9
Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure.一家高并发非阿片类药物(多药物滥用)暴露率的三级护理医院中,患有新生儿阿片戒断综合征的婴儿的住院治疗结果。
Am J Perinatol. 2022 Mar;39(4):387-393. doi: 10.1055/s-0040-1716490. Epub 2020 Sep 6.
10
Polysubstance Use Among Pregnant Women With Opioid Use Disorder in the United States, 2007-2016.美国 2007-2016 年阿片类药物使用障碍孕妇的多药物使用情况。
Obstet Gynecol. 2020 Sep;136(3):556-564. doi: 10.1097/AOG.0000000000003907.